Mobile app for managing Type 2 diabetes
mHealth Lifestyle Management Program (LIVEN) For Adults With Diabetes Type 2: A Feasibility Study
This study is testing a new mobile app that helps adults with Type 2 diabetes improve their lifestyle and manage their blood sugar better compared to regular treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Princess Nourah Bint Abdulrahman University Academic / other |
| Locations | 1 site (Riyadh, Riyadh Region) |
| Trial ID | NCT05630508 on ClinicalTrials.gov |
What this trial studies
This study evaluates a 12-week health coaching mobile application called LIVEN aimed at improving lifestyle behaviors in adults with Type 2 Diabetes compared to standard treatment. The study is divided into two phases: the first assesses the usability of the app for both patients and health coaches, while the second focuses on the effectiveness of the educational materials and coaching program in enhancing lifestyle behaviors and blood sugar levels. The investigators hypothesize that the program will be feasible and lead to a full-scale study.
Who should consider this trial
Good fit: Ideal candidates are Arabic-speaking adults aged 18 and older with Type 2 Diabetes and poor glycemic control.
Not a fit: Patients using insulin injections or those with other serious health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve lifestyle management and glycemic control for patients with Type 2 Diabetes.
How similar studies have performed: Other studies have shown promise in using mobile health applications for diabetes management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults, aged 18 years or older * Arabic speakers * Capable of utilizing smartphones * Diagnosed with T2DM * Poor glycemic control: A1c \> 7.5% Exclusion Criteria: * Individuals using insulin injection * Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease) * Women who are pregnant or breastfeeding * Individuals diagnosed with other types of diabetes (such as type I or MODY)
Where this trial is running
Riyadh, Riyadh Region
- Princess Nourah bint Abdulrahman University — Riyadh, Riyadh Region, Saudi Arabia (Recruiting)
Study contacts
- Study coordinator: Shaima A Alothman, PhD
- Email: shaalothman@pnu.edu.sa
- Phone: +966503952053
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.